Skip to main content

ADVERTISEMENT

Jeffrey H. Freihage, MD

Original Contribution
08/01/2008
Conflicting opinions exist regarding the optimal dose of acetyl salicylic acid (ASA) to be given after percutaneous coronary intervention (PCI) with drug-eluting stents (DES). The Seventh ACCP Conference on Antithrombotic and Thrombolytic...
Conflicting opinions exist regarding the optimal dose of acetyl salicylic acid (ASA) to be given after percutaneous coronary intervention (PCI) with drug-eluting stents (DES). The Seventh ACCP Conference on Antithrombotic and Thrombolytic...
Conflicting opinions exist...
08/01/2008
Journal of Invasive Cardiology